InvestorsHub Logo
icon url

BugStocks_com

01/22/21 9:27 AM

#11684 RE: Bri798 #11683

I can’t bang the table harder, do the math... 202m cap for KAVL and 18.6b for RLX is 1:92 ratio... their sales # are closer than you think. Yeah China has a bigger market, no doubt, but KAVL could easily be 1/10th of their size/valuation... that means 900-1000% gains puts us at that ratio. Now what if RLX climbs to $17-$20 first day... it just blows that ratio up more. Heck, everyone loves a 100% winner... that would still only put KAVL at $1.50 and 1/50th of RLX... to get to NASDAQ requirements they’d still be 1/20th the size of RLX value wise... yet RLX is doing only 2x the revs??
icon url

BugStocks_com

01/22/21 10:23 AM

#11687 RE: Bri798 #11683

Operating under the RELX brand, the company boasts a 62.6% market share in China for closed-system e-vapor products in terms of retail sales. The company has partnered with 110 authorized distributors to supply its products to over 5,000 RELX Branded Partner Stores, and over 100,000 other retail outlets nationwide, covering over 250 cities in China. Revenue nearly doubled in the nine months ended September 30, 2020 to $324 million, with net income of $16 million.

KAVL could do $400-$450 million this year, those #’s are legitimately comparable...

My questions to everyone are... Should RLX trade at a value of 90x higher? How undervalued is KAVL?